Literature DB >> 7888297

N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients.

C Deloménie, D M Grant, P Mathelier-Fusade, C Jacomet, F Leynadier, E Jacqz-Aigrain, W Rozenbaum, R Krishnamoorthy, J M Dupret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7888297      PMCID： PMC1364923          DOI： 10.1111/j.1365-2125.1994.tb04401.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  Molecular genetics of the N-acetyltransferases.

Authors:  D M Grant
Journal:  Pharmacogenetics       Date:  1993-02

2.  Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients.

Authors:  A Carr; A S Gross; J M Hoskins; R Penny; D A Cooper
Journal:  AIDS       Date:  1994-03       Impact factor: 4.177

3.  Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome.

Authors:  B L Lee; D Wong; N L Benowitz; P M Sullam
Journal:  Clin Pharmacol Ther       Date:  1993-05       Impact factor: 6.875

4.  Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.

Authors:  F M Gordin; G L Simon; C B Wofsy; J Mills
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

5.  Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity.

Authors:  N H Shear; S P Spielberg; D M Grant; B K Tang; W Kalow
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391
  5 in total
  8 in total

1.  Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS.

Authors:  W M O'Neil; J C Pezzullo; A Di Girolamo; C M Tsoukas; I W Wainer
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.

Authors:  Olayinka A Kotila; Olufunmilayo I Fawole; Olufunmilayo I Olopade; Adejumoke I Ayede; Adeyinka G Falusi; Chinedum P Babalola
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089

3.  Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.

Authors:  Ana Alfirevic; Anne C Stalford; F Javier Vilar; Ed G L Wilkins; B Kevin Park; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

4.  Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.

Authors:  Justin J Wilkins; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 5.  Role of viral infections in the induction of adverse drug reactions.

Authors:  M Levy
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.228

6.  Variability in drug metabolizing enzyme activity in HIV-infected patients.

Authors:  Amanda E Jones; Kevin C Brown; Rebecca E Werner; Karl Gotzkowsky; Andrea Gaedigk; Mike Blake; David W Hein; Charles van der Horst; Angela D M Kashuba
Journal:  Eur J Clin Pharmacol       Date:  2010-01-19       Impact factor: 2.953

7.  Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide Antimicrobials.

Authors:  Jennifer M Reinhart; Alison Motsinger-Reif; Allison Dickey; Steven Yale; Lauren A Trepanier
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

8.  Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.

Authors:  Yat Yee Wong; Brian Johnson; Thomas C Friedrich; Lauren A Trepanier
Journal:  Pharmacol Res Perspect       Date:  2017-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.